Skip to main content

Advertisement

Log in

Mechanisms of development and progression of cyanotic nephropathy

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Cyanotic nephropathy (CN) is often accompanied by congenital cyanotic heart diseases (CCHD). The purpose of this study was to clarify the risk factors and the mechanisms of involved in the development and progression of CN. Thirty patients with CCHD were examined. We analyzed the risk factors for the development of CN on the basis of the clinical and laboratory findings. We also examined ten renal biopsy specimens obtained from patients with CN. Patients with CN showed significantly higher hematocrit levels than those without CN (P=0.025), although there was no difference between the two groups in terms of oxygen saturation. The renal plasma flow (RPF) in patients both with and without CN was low. However, the filtration fraction (FF) was significantly lower in patients with CN than in those without CN (P=0.001). The glomeruli of biopsy specimens with significant proteinuria (n=7) were larger than those of biopsy specimens without significant proteinuria, and there were more capillaries per glomerulus in the former than in the latter (n=3) and the control specimens (n=6) (glomerular size: P<0.01; number of glomerular capillaries: P<0.01). In conclusion, hyperviscosity by polycythemia may be responsible for the development of CN. This pathological condition may induce an angiogenic increase in the glomerular capillary beds, in turn leading to glomerulomegaly. In addition, the failure of a compensatory mechanism to respond to reduced RPF by hyperfiltration may be accompanied by the development and progression of CN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Spear GS (1964) The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. A review. Nephron 1:238–248

    Article  CAS  Google Scholar 

  2. Spear GS (1960) Glomerular alterations in cyanotic congenital heart disease. Bull Johns Hopkins Hosp 106:347–367

    CAS  PubMed  Google Scholar 

  3. Tanaka J, Yasui H, Nakano E, Sese A, Matsui K, Takeda Y, Tokunaga K (1980) Predisposing factors of renal dysfunction following total correction of tetralogy of Fallot in the adult. J Thorac Cardiovasc Surg 80:135–140

    CAS  PubMed  Google Scholar 

  4. Perloff JK, Latta H, Barsotti P (2000) Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 86:1198–1204

    Article  CAS  Google Scholar 

  5. Wilcox CS, Deng X, Doll AH, Snellen H, Welch WJ (1993) Nitric oxide mediates renal vasodilatation during erythropoietin-induced polycythemia. Kidney Int 44:430–435

    Article  CAS  Google Scholar 

  6. Dittrich S, Kurschat K, Lange PE (2001) Abnormal rheology in cyanotic congenital heart disease–a factor in non-immune nephropathy. Scand J Urol Nephrol 35:411–415

    Article  CAS  Google Scholar 

  7. Dittrich S, Haas NA, Buhrer C, Muller C, Dahnert I, Lange PE (1998) Renal impairment in patients with long standing cyanotic congenital heart disease. Acta Paediatr 87:949–954

    Article  CAS  Google Scholar 

  8. Agras PI, Derbent M, Ozcay F, Baskin E, Turkoglu S, Aldemir D, Tokel K, Saatci U (2005) Effect of congenital heart disease on renal function in childhood. Nephron Physiol 99:10–15

    Article  Google Scholar 

  9. Hagley MT, Murphy DP, Mullins D, Zarconi J (1992) Decline in creatinine clearance in a patient with glomerulomegaly associated with a congenital cyanotic heart disease. Am J Kidney Dis 20:177–179

    Article  CAS  Google Scholar 

  10. Weibel ER (1979) Stereological methods: practical methods for biological morphometry, vol. 1. Academic Press, London, pp 40–160

    Google Scholar 

  11. Krull F, Ehrich JH, Wurster U, Toel U, Rothganger S, Luhmer I (1991) Renal involvement in patients with congenital cyanotic heart disease. Acta Paediatr Scand 80:1214–1219

    Article  CAS  Google Scholar 

  12. Burke JR, Glasgow EF, McCredie DA, Powell HR (1977) Nephropathy in cyanotic congenital heart disease. Clin Nephrol 7:38–42

    PubMed  Google Scholar 

  13. Hida K, Wada J, Yamasaki H, Nagake Y, Zhang H, Sugiyama H, Shikata K, Makino H (2002) Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. Nephrol Dial Transplant 17:144–147

    Article  Google Scholar 

  14. Fogo A, Hawkins EP, Berry PL, Glick AD, Myra LC, MacDonell RC, Ichikawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115–123

    Article  CAS  Google Scholar 

  15. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG (1989) Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60:205–218

    CAS  PubMed  Google Scholar 

  16. Nagata M, Kriz W (1992) Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42:148–160

    Article  CAS  Google Scholar 

  17. Eckardt KU, Hartmann W, Vetter U, Pohlandt F, Burghardt R, Kurtz A (1990) Serum immunoreactive erythropoietin of children in health and disease. Eur J Pediatr 149:459–464

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This study was partially supported by a Health and Labor Sciences Research Grant (H16-Kodomo-015 to Dr. Iijima) and a Grant for Child Health and Development (16C-2 to Dr. Iijima).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazumoto Iijima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inatomi, J., Matsuoka, K., Fujimaru, R. et al. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 21, 1440–1445 (2006). https://doi.org/10.1007/s00467-006-0220-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0220-5

Keywords

Navigation